An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis

Journal of Neurology

Volumn 258, Issue 2, 2011, Pages 238-243

  Zoccolella, Stefano ^a   Simone, Isabella Laura ^b   Capozzo, Rosa ^b   Tortelli, Rosanna ^b   Leo, Antonio ^b   D'Errico, Eustachio ^b   Logroscino, Giancarlo ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Oxidative stress; Phenotype; Progression; Urate

Indexed keywords

URATE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; EXPLORATORY RESEARCH; FEMALE; HUMAN; KIDNEY FUNCTION; LIMB; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; URIC ACID;

EID: 79953781989     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5735-9     Document Type: Article

References (38)

1. Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688-1700 (Pubitemid 32479968)
2. Goodall EF, Morrison KE (2006) Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev Mol Med 8:1-22 (Pubitemid 43904876)
3. Oda M, Satta Y, Takenaka O et al (2002) Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 19:640-653 (Pubitemid 34521296)
4. Ames BN, Cathcart R, Schwiers E et al (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Nal Acad Sci USA 78:6858-6862 (Pubitemid 12216861)
5. Yu ZF, Bruce-Keller AJ, Goodman Y et al (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 53:613-625 (Pubitemid 28380802)
6. Church WH, Ward VL (1994) Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation. Brain Res Bull 33:419-425
7. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495-505
8. Davis JW, Grandinetti A, Waslien CJ et al (1996) Observations on serum uric acid and the risk for idiopathic Parkinson's disease. Am J Epidemiol 144:480-484 (Pubitemid 26296131)
9. Weisskopf MG, O'Reilly E, Chen H et al (2007) Plasma urate and risk of Parkinson's disease. Am J Epidemiol 166:561-567
10. De Vera M, Rahman MM, Rankin J et al (2008) Gout and the risk of Parkinson's disease: a cohort study. Arthritis Rheum 59:1549-1554
11. de Lau LM, Koudstaal PJ, Hofman A et al (2005) Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 58:797-800 (Pubitemid 41552559)
12. Gao X, Chen H, Choi HK et al (2008) Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol 167:831-838 (Pubitemid 351451751)
13. Alonso A, Rodríguez LA, Logroscino G et al (2007) Gout and risk of Parkinson disease: a prospective study. Neurology 69:1696-1700 (Pubitemid 350287126)
14. Irizarry MC, Raman R, Schwarzschild MA et al (2009) Plasma urate and progression of mild cognitive impairment. Neurodegener Dis 6:23-28
15. Euser SM, Hofman A, Westendorp RG et al (2009) Serum uric acid and cognitive function and dementia. Brain 132:377-382
16. Schretlen DJ, Inscore AB, Jinnah HA et al (2007) Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 21:136-140 (Pubitemid 46066213)
17. Ruggiero C, Cherubini A, Miller E et al (2007) Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol 100:115-121 (Pubitemid 46961911)
18. Keizman D, Ish-Shalom M, Berliner S et al (2009) Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci 285:95-99
19. Sohmiya M, Tanaka M, Suzuki Y et al (2005) An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients. J Neurol Sci 228:49-53 (Pubitemid 39656494)
20. Kokic AN, Stevic Z, Stojanovic S et al (2005) Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Redox Rep 10:265-270 (Pubitemid 44111133)
21. Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124(Suppl):96-107
22. Miller RG, Munsat TL, Swash M et al (1999) Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sci 169:2-12 (Pubitemid 29502500)
23. Bos MJ, Koudstaal PJ, Hofman A et al (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37:1503-1507 (Pubitemid 44305733)
24. Brooks BR (2003) Functional scales: summary. Amyotroph Lateral Scler Other Motor Neuron Disord 3(suppl1):S13-S18
25. Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265-267 (Pubitemid 43970171)
26. Levey AS, Coresh J, Greene T et al (2007) Chronic kidney disease epidemiology collaboration. expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766-772 (Pubitemid 46580250)
27. Reynolds A, Laurie C, Lee Mosley R et al (2007) Oxidative stress and the pathogenesis of neurodegenerative disorders. Intern Rev Neurobiol 82:297-325
28. Hervias I, Beal MF, Manfredi G (2006) Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve 33:598-608
29. Pacher P, Beckman KS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424 (Pubitemid 46217686)
30. Tohgi H, Abe T, Yamazaki K et al (1999) Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci Lett 260:204-206 (Pubitemid 29089196)
31. Du Y, Chen CP, Tseng CY et al (2007) Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia 55:463-472 (Pubitemid 46383176)
32. Ruggiero C, Cherubini A, Lauretani F et al (2009) Uric acid and dementia in community-dwelling older persons. Dement Geriatr Cogn Disord 27:382-389
33. Schiess M, Oh I (2008) Serum uric acid and clinical progression in Parkinson disease. Potential biomarker for nigrostriatal failure. Arch Neurol 65:698-699
34. Ruggiero C, Cherubini A, Ble A et al (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174-1181
35. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-521 (Pubitemid 37237047)
36. Hayden MR, Tyagi SC (2004) Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 1(1):10
37. Gasteyger C, Suter M, Calmes JM et al (2006) Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding. Obes Surg 16:243-250
38. Traynor BJ, Bruijn L, Conwit R et al (2006) Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology 67:20-27 (Pubitemid 44305456)